View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

BioNTech beginnt öffentliches Umtauschangebot für alle ausstehenden Ak...

BioNTech beginnt öffentliches Umtauschangebot für alle ausstehenden Aktien von CureVac N.V. Geplante Übernahme soll Forschung, Entwicklung, Herstellung und Kommerzialisierung von mRNA-basierten Krebsimmuntherapie-Kandidaten stärken und ist ein weiterer Meilenstein in der Umsetzung von BioNTechs Onkologie-StrategieCureVac-Aktionärinnen und -Aktionäre erhalten für jede CureVac-Aktie BioNTech American Depositary Shares im Wert von ca. 5,46 US-Dollar, wobei das Umtauschverhältnis einem Anpassungsmechanismus unterliegt; ein Richtwert für das Umtauschverhältnis wird während der Laufzeit des Umtau...

 PRESS RELEASE

BioNTech Commences Public Exchange Offer for All Outstanding Shares of...

BioNTech Commences Public Exchange Offer for All Outstanding Shares of CureVac N.V. Acquisition aims to strengthen the research, development, manufacturing and commercialization of mRNA-based cancer immunotherapy candidates, marking BioNTech’s next milestone in the execution of its oncology strategyCureVac shareholders receive approximately $5.46 in BioNTech American Depositary Shares for each CureVac share, subject to a collar; an indicative exchange ratio will be available at for the duration of the exchange offerInformation on how CureVac shareholders can participate in the exchange off...

Julian Dobrovolschi
  • Julian Dobrovolschi

Generali: 1 director

A director at Generali sold 30,000 shares at 32.963EUR and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showi...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Ageas: AG Real Estate looking to reduce exposure to Interparking, lower capital charges. Air France-KLM: 3Q25 a bit light? ASML: Preview 3Q25, riding the AI wave. Barco: Preview 3Q25, self-help offsets macro headwind. D'Ieteren: Belron starts to roll out static mobile recalibration. Euronext: September's seasonal recovery. Tessenderlo More focus on capital allocation and returns. TomTom: Preview 3Q25, Cost cutting offsets slow markets. Umicore: Gold inventory sale-and-lease-back

 PRESS RELEASE

Euronext announces volumes for September 2025

Euronext announces volumes for September 2025 Euronext announces volumes for September 2025 Amsterdam, Brussels, Dublin, Lisbon, Milan, Oslo and Paris – 7 October 2025 – Euronext, the leading European capital market infrastructure, today announced trading volumes for September 2025. Monthly and historical volume tables are available at this address: CONTACTS   ANALYSTS & INVESTORS – Investor Relations        Judith Stein         97         Margaux Kurver         03 MEDIA –   Europe        Andrea Monzani          13         Sandra Machado         7 Belgium        Marianne Aald...

 PRESS RELEASE

Euronext announces the launch of the voluntary exchange offer for all ...

Euronext announces the launch of the voluntary exchange offer for all ATHEX shares Euronext announces the launch of the voluntary exchange offer for all ATHEX shares Euronext has received regulatory approval to launch a voluntary exchange offer to acquire all common registered ATHEX sharesAcceptance Period commences on 6 October 2025 and will end on 17 November 2025 A significant step towards a more integrated and more competitive capital market in Europe, establishing ATHEX as a financial hub in the Southeast Europe regionATHEX to join Euronext’s best-in-class trading and post-trade tech...

 PRESS RELEASE

Euronext N.v. Has Received the Relevant Regulatory Approvals for the C...

Euronext N.v. Has Received the Relevant Regulatory Approvals for the Commencement of the Acceptance Period of the Voluntary Share Exchange Offer for the Ordinary Registered Shares of Hellenic Exchanges-Athens Stock Exchange NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO ANY JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE PROHIBITED BY, OR CONSTITUTE A VIOLATION OF, THE RELEVANT LAWS OF THAT JURISDICTION OR REQUIRE EURONEXT AND/OR ATHEX TO TAKE ANY FURTHER ACTION. PLEASE SEE THE IMPORTANT DISCLAIMERS AT THE END...

Michael B. Schäfer
  • Michael B. Schäfer
Carole Braudeau
  • Carole Braudeau

Credit Morning 09/26/2025

Donald Trump announces 100% tariffs on imported branded drugs|Kantar : Moody’s cuts the rating to B3/stable from B2/stable|

Carole Braudeau
  • Carole Braudeau

Morning Crédit 26/09/2025

Donald Trump annonce des droits de douane de 100% sur les médicaments brevetés produits hors des US|Kantar : Moody’s dégrade le rating de B2/stable à B3/stable|

 PRESS RELEASE

BioNTech veranstaltet am 1. Oktober 2025 zweiten „AI Day“ als eine Aus...

BioNTech veranstaltet am 1. Oktober 2025 zweiten „AI Day“ als eine Ausgabe der „Innovation Series“   MAINZ, Deutschland, 23. September 2025 (GLOBE NEWSWIRE) --  (Nasdaq: BNTX, „BioNTech“) richtet zusammen mit ihrem Tochterunternehmen für künstliche Intelligenz (artificial intelligence, „AI“), („InstaDeep“), am Dienstag, den 1. Oktober 2025 um 15:00 Uhr MESZ (09:00 Uhr EDT) ihren zweiten „AI Day“ aus, eine Ausgabe von BioNTechs „Innovation Series“ in London, Vereinigtes Königreich. Die Veranstaltung gibt einen Überblick über die Strategie und die Fähigkeiten von BioNTech im Bereich AI und...

 PRESS RELEASE

BioNTech to Host Second AI Day as an Edition of Its Innovation Series ...

BioNTech to Host Second AI Day as an Edition of Its Innovation Series on October 1, 2025 MAINZ, Germany, September 23, 2025 (GLOBE NEWSWIRE) --  (Nasdaq: BNTX, “BioNTech”), alongside its artificial intelligence (“AI”) company (“InstaDeep”), will host its second AI Day, an edition of BioNTech’s “Innovation Series”, at 09:00 a.m. EDT (3:00 p.m. CEST) on Wednesday, October 1, 2025, in London, United Kingdom. The event will provide an overview of BioNTech’s AI strategy and capabilities, and the application of AI in BioNTech’s pipeline and internal processes. The live webcast of the event will...

 PRESS RELEASE

Euronext announces completion of share repurchase programme as part of...

Euronext announces completion of share repurchase programme as part of its long-term incentive plan Euronext announces completion of share repurchase programme as part of its long-term incentive plan         Amsterdam, Brussels, Dublin, Lisbon, Milan, Oslo and Paris – 22 September 2025 – Euronext announces that it has completed the repurchase of 101,000 of its own shares at an average share price of €137.75. This programme was carried out within the scope of the Euronext Long-Term Incentive plan by an independent agent from 4 September to 19 September and in accordance with the conditions...

Moody's Ratings assigns Baa1 rating to Symrise AG proposed notes

Moody's Ratings (Moody's) assigned a Baa1 instrument rating to Symrise AG's (Symrise or the company) proposed senior unsecured benchmark size notes. Symrise's Baa1 long-term issuer ratings remains unaffected. The outlook is stable. RATINGS RATIONALE The Baa1 rating of the proposed senior unsecur...

Daimler Truck : Sustainability Weekly 8 - 12 September 2025

Last week, we published a report in which we propose ideas on the theme of sustainable sovereignty. Technip Energies signed an agreement to acquire the Advanced Materials & Catalysts business of Ecovyst Inc, a global leader in specialty catalysts and advanced materials. The IEA is expected to reintroduce its slow transition scenario, ‘Current Policies’, in its next World Energy Outlook, probably under pressure from the Trump administration. German Chancellor Merz has hinted at a slowdown in the ...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch